Dopaminergic News and Research

RSS

Computational platform predicts how to convert one cell type into another

Researchers have developed a computational platform that predicts how one subtype of cells can be converted into another subtype.

30 Jul 2018

Researchers uncover why people with Parkinson's disease suffer from sleep disturbances

A team of researchers at VIB and KU Leuven has uncovered why people with a hereditary form of Parkinson's disease suffer from sleep disturbances.

8 Jun 2018

Scientists find key biomarker of Parkinson's disease in the retina

A research involving scientists from the University of Alicante and the United States notes that the accumulation of a protein known as alpha-synuclein in the retina is a key Parkinson's biomarker that could help detect the degree of severity of the disease.

8 Jun 2018

Cognitive training intervention reduces gait freezing in Parkinson's patients, study shows

The researchers report significant reduction in the severity and duration of freezing of gait, improved cognitive processing speed and reduced daytime sleepiness.

18 May 2018

Scientists make breakthrough in visualizing human brain tissue at microscopic level

A team of scientists from the Li Ka Shing Faculty of Medicine of The University of Hong Kong and Imperial College London has made a breakthrough in the visualization of human brain tissue at the microscopic level.

7 May 2018

Cedars-Sinai research sheds light on how the brain rapidly forms new memories

Research from Cedars-Sinai sheds light on how the human brain rapidly forms new memories, providing insights into potential new treatments for memory disorders.

2 May 2018

Binge eating in Parkinson's disease patients associated with working memory deficit

Binge eating, as if the impulse of the moment could not be contrasted by a deeper thought, which would lead to maintaining a healthier eating behavior.

3 Apr 2018

Study describes new protection mechanisms to fight neurodegeneration in Parkinson's and Alzheimer's

A new research study reveals RAC1 protein could be a new therapeutic target to study the molecular mechanisms related to the neurodegenerative processes in Parkinson's disease.

20 Feb 2018

Administration of two proteins shown to counteract neurodegeneration in Parkinson's disease

A combination therapy made up of two neurotrophic factors can reduce the degenerative effects of Parkinson’s disease, shows new research.

15 Jan 2018

Synergy between two neurotrophic factors exerts beneficial effect in early phase of Parkinson’s disease

Parkinson's disease is currently the second most widespread neurogenerative pathology. Current therapies are mainly of a replacement type and pose problems in the long term, so the challenge is to establish an early diagnosis and develop neuroprotective and neurorestorative therapies that will allow the symptoms of the disease to be slowed down or even reversed.

12 Jan 2018

Study finds new brainstem changes in Parkinson’s disease

A pioneering study has found that patients with Parkinson's disease have more errors in the mitochondrial DNA within the brainstem, leading to increased cell death in that area.

4 Jan 2018

Combining virtual reality and treadmill training improves neuroplasticity in Parkinson's patients

A new Tel Aviv University study suggests that a therapy that combines Virtual Reality and treadmill exercise dramatically lowers the incidence of falling among Parkinson's patients by changing the brain's behavior and promoting beneficial brain plasticity, even in patients with neurodegenerative disease.

28 Nov 2017

Scientists find key that allows neural differentiation of microRNA-deficient pluripotent stem cells

The more than 200 different types of human cells have the same DNA but express different ensembles of genes. Each cell type was derived from embryonic stem cells, which are called pluripotent stem cells because they can differentiate to all those different cell fates.

15 Nov 2017

Research suggests possibility of preventing and treating Parkinson's disease using licorice extract

DGIST's research team led by Dr. Yun-Il Lee in Well-Aging Research Center has identified a new mechanism of inhibition of dopaminergic neuronal apoptosis and suggested the possibility of preventing and treating Parkinson's disease.

8 Nov 2017

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the presentation of data from the Phase II -019 Study of pimavanserin in Alzheimer's disease psychosis at the 10th Clinical Trials on Alzheimer's Disease meeting in Boston.

3 Nov 2017

Reprogrammed stem cell therapy shows promise in Parkinson's

Japanese investigators have found that their experimental stem cell therapy for Parkinson’s disease actually works. In their experimental therapy, the team of researchers “reprogrammed” stem cells to make them neurons and implanted them into the brain of monkeys with a version of Parkinson’s disease. Stem cell therapy showed improvement of symptoms in these patients and was found to be safe. The study was published yesterday, 30th August 2017 in Nature.

30 Aug 2017

Dopaminergic News and Research

Computational platform predicts how to convert one cell type into another

Researchers uncover why people with Parkinson's disease suffer from sleep disturbances

Scientists find key biomarker of Parkinson's disease in the retina

Cognitive training intervention reduces gait freezing in Parkinson's patients, study shows

Scientists make breakthrough in visualizing human brain tissue at microscopic level

Cedars-Sinai research sheds light on how the brain rapidly forms new memories

Binge eating in Parkinson's disease patients associated with working memory deficit

Study describes new protection mechanisms to fight neurodegeneration in Parkinson's and Alzheimer's

Administration of two proteins shown to counteract neurodegeneration in Parkinson's disease

Synergy between two neurotrophic factors exerts beneficial effect in early phase of Parkinson’s disease

Study finds new brainstem changes in Parkinson’s disease

Combining virtual reality and treadmill training improves neuroplasticity in Parkinson's patients

Scientists find key that allows neural differentiation of microRNA-deficient pluripotent stem cells

Research suggests possibility of preventing and treating Parkinson's disease using licorice extract

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

Reprogrammed stem cell therapy shows promise in Parkinson's

Bacterial community in the gut of Parkinson's patients differs from that of healthy people

Traumatic brain injuries in kids could be risk-factor for alcohol abuse in later life

Low-dose anxiolytics can ameliorate social disadvantage related to trait anxiety

New approaches to early detection of Parkinson's disease on the horizon

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News